Nicorette Invisi 10 mg/16 h, transdermales Pflaster

7680581750025 CH-58175 Transdermales Pflaster
Nicorette Invisi 10 mg/16 h, transdermales Pflaster
Nicorette Invisi 10 mg/16 h, transdermales Pflaster
Nicorette Invisi 10 mg/16 h, transdermales Pflaster
1 / 3
google

Article details

Package size
14
Selling units
14
Measure
Pflaster
Galenic form
Transdermales Pflaster
Galenic group
Pflaster/Transdermale Systeme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/05/2025
Summary of Product Characteristics
Français
13/05/2025
Summary of Product Characteristics
Italien
13/05/2025
Patient information leaflet
Allemand
14/12/2023
Patient information leaflet
Français
14/12/2023
Patient information leaflet
Italien
14/12/2023

Detailed composition

Substance Quantity Type Category
(N/A)
15.75 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

JNTL Consumer Health II

6343 Risch

Authorization information

Swissmedic authorization number
58175
Drug name
Nicorette Invisi, transdermales Pflaster
Galenic form
TRAP
ATC Code
N07BA01
Authorization status
Z
Dispensing category
D
First authorization
17/09/2009
Authorization expiration date
31/12/9999
IT Number
15.02.0.
Domain
Human medicine
Field of application
Unterstützung der Raucherentwöhnung

Package details

Description (FR)
NICORETTE Invisi patch 10 mg/16h 14 pce
Description (DE)
NICORETTE Invisi Patch 10 mg/16h 14 Stk
Market launch
17/09/2009
Narcotic (BTM)
No

Other package sizes (7)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
NICORETTE Invisi patch 15 mg/16h 14 pce
14 PFLA
GTIN: 7680581750049
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
NICORETTE Invisi patch 25 mg/16h 14 pce
14 PFLA
GTIN: 7680581750070
View
None
None None
GTIN: None
Not in V1